Argenta has appointed Terry Jackson as its new Global Head of Quality Assurance and Regulatory Affairs. Jackson brings over 25 years of experience with leadership roles within companies such as Dechra, Catalent, and Pfizer Animal Health.
One of the leading animal health pharmaceutical services companies, Argenta has announced the appointment of Terry Jackson as the Global Head of Quality Assurance (QA) and Regulatory Affairs, effective immediately.
As a leader of high-performance quality organisations within the pharmaceutical industry in both human and animal health, Jackson brings over 25 years of experience with leadership roles within companies such as Dechra, Catalent, and Pfizer Animal Health. Most recently, he was the Head of Quality of the Shawnee site which was recently acquired by Argenta.
“I am thrilled to welcome Terry to Argenta. He has a proven track record, and I believe his expertise and leadership will help enable our ability to deliver for our clients while upholding the highest standards of quality and regulatory compliance,” says Stephan Kutzer, Interim CEO and Board Member at Argenta.
Terry Jackson will join the Executive Leadership Team and oversee the QA and Regulatory Affairs organisations across Argenta’s CDMO and CRO service platforms, reporting directly to the CEO.
